Motor Neurons Morphology Assay
Motor neurons are a specialized type of nerve cell that transmits signals from the brain or spinal cord to muscles, enabling voluntary movement. The morphology, or physical structure, of motor neurons is essential for their proper function, and any abnormalities can lead to various neurodegenerative diseases, such as ALS and SMA. Therefore, the characterization of motor neuron morphology is crucial for understanding their structure and function and developing effective therapies for motor neuron diseases. Creative Biolabs offers a comprehensive range of characterization services for motor neurons.
Motor Neuron Production
Induced pluripotent stem cells (iPSCs), which present new opportunities for modeling disease processes and screening drug libraries of the central nervous system (CNS). We have developed technology to produce very large quantities of highly enriched human neurons from patient iPSCs and to greatly accelerate their maturation. The workflow for producing motor neurons from induced pluripotent stem cells (iPSCs) involves several critical steps, including iPSC generation, NPC differentiation, motor neuron differentiation, and quality control testing.
Fig.1 General workflow for Neuron Production. (Faye, 2020)
Motor Neuron Cell Bodies/Neurites Assay
Motor neuron morphology assays involve the analysis of various morphological features of motor neurons, such as dendritic arborization, axonal length, and branching patterns. These features can provide insights into the cellular mechanisms underlying motor neuron development, plasticity, and degeneration. At Creative Biolabs, we offer motor neuron morphology assay services using state-of-the-art techniques, such as immunofluorescence staining, confocal microscopy, and image analysis. Our assays are highly sensitive and can detect subtle changes in motor neuron morphology, making them valuable tools for studying motor neuron diseases.
Motor Neuron High-content Imaging Service
Creative Biolabs has developed two high-throughput screening (HTS) systems using human motor neurons derived from individuals with amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA). Using genome editing techniques on the iPSC lines, the reporter nanoluciferase (Nluc) was fused to endogenous neurofilament light chain (NFL) for ALS and full-length SMN2 for SMA. Nanoluciferase is more sensitive than the traditional luciferase and allows for a simple and quantitative readout of NFL and SMN2 protein levels. This cell model system demonstrates the feasibility of running HTS campaigns using human neurons, which present a more physiologically relevant drug discovery platform.
Fig. 2 Images of neurite deterioration at 24 Hours (left) and 48 Hours (right). (Li, 2021)
Our Advantages
Expert Team
State-of-the-Art Technologies
Customized Services
Quality Assurance
In conclusion, the characterization of motor neuron morphology is essential for understanding their structure and function and developing effective therapies for motor neuron diseases. Creative Biolabs is committed to providing customized and high-quality services to our clients. If you are looking for reliable and efficient motor neuron characterization services, get in touch with us today to find out more about how we can support you in your endeavors!
References
- Faye, Pierre-Antoine, et al. "Optimized protocol to generate spinal motor neuron cells from induced pluripotent stem cells from charcot marie tooth patients." Brain Sciences 10.7 (2020): 407.
- Li, Shuaizhang, et al. "Evaluation of chemical compounds that inhibit neurite outgrowth using GFP-labeled iPSC-derived human neurons." Neurotoxicology 83 (2021): 137-145.
- NeuroMab™ Mouse Anti-LRP1 Monoclonal Antibody (CBP3363) (Cat#: NAB-0720-Z6479)
- NeuroMab™ Anti-pTau Antibody(NRP-0422-P1719) (Cat#: NRP-0422-P1719)
- NeuroMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- NeuroMab™ Anti-CD20 Antibody(NRP-0422-P1230) (Cat#: NRP-0422-P1230)
- NeuroMab™ Anti-ApoC3 BBB Shuttle Antibody(NRZP-1022-ZP3505) (Cat#: NRZP-1022-ZP3505)
- NeuroMab™ Anti-FGFR1 Antibody(NRP-0422-P1244) (Cat#: NRP-0422-P1244)
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P1683) (Cat#: NRP-0422-P1683)
- NeuroMab™ Anti-TREM2 BBB Shuttle Antibody(NRZP-1022-ZP4114) (Cat#: NRZP-1022-ZP4114)
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P2293) (Cat#: NRP-0422-P2293)
- NeuroMab™ Anti-GD2 Antibody(NRZP-1222-ZP767) (Cat#: NRZP-1222-ZP767)
- Mouse Microglia N9 (Cat#: NCL2110P073)
- Rat Olfactory Ensheathing Cells (Cat#: NRZP-1122-ZP162)
- Mouse Microglia from C57BL/6 (Cat#: NCL-21P6-082)
- Human Brain Astroblastoma U-87 MG (Cat#: NCL2110P117)
- Human Brain Microvascular Endothelial Cells (Cat#: NCL-2103-P133)
- Human Blood Brain Barrier Model (Cat#: NCL-2103-P187)
- Human Glioblastoma Cell Line SF126 (Cat#: NCL-2108P35)
- Rat Muller Cell (Cat#: NCL2110P040)
- Mouse Glioma Cell Line GL261 (Cat#: NCL-2108P28)
- iNeu™ Retinal Pigment Epithelial Cells (RPE) (Cat#: NRZP-0323-ZP92)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- pAAV-syn-jGCaMP8m-WPRE (Cat#: NTA-2106-P062)
- AAV2/9-hSyn-Flpo-EGFP-WPRE-pA (Cat#: NTA-2012-ZP149)
- pAAV-syn-jGCaMP8f-WPRE (Cat#: NTA-2106-P061)
- Dextran-FITC (Cat#: NTA-2011-ZP110)
- pAAV-EF1a-DIO-EGFP-WPRE (Cat#: NTA-2012AD-P285)
- pAAV-syn-jGCaMP8s-WPRE (Cat#: NTA-2106-P063)
- Dextran, NHS Activated, 40 kDa (Cat#: NRZP-0722-ZP124)
- AAV2/2Retro-CAG-DIO-EGFP-2A-TetTox-pA [Neural Tracing] (Cat#: NTA-2012-ZP303)
- rAAV-CAG-DIO-G-Flamp1 (Cat#: NRZP-0722-ZP719)
- Dextran-CYanine5.5 (Cat#: NTA-2011-ZP118)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)